Friso MUM, the activity of a health supplement during pregnancy and lactatio

Completed

• Conditions: Developmental disorder; Mental and Behavioural Disorders; Mixed specific developmental disorders

• Registration Number: ISRCTN58176213
• Lead Sponsor: Friesland Foods (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

1. Apparently healthy pregnant women
2. Para 0 or 1
3. Inclusion should take place prior to the 16th week of pregnancy

Exclusion Criteria

1. Hyperemesis Gravidarum
2. Vegetarian or vegan
3. Pregnant with twins
4. Diabetes Mellitus type 1
5. Usage of health supplements with fatty acids, tryptophan or melatonin

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurological development of the baby (Neurological Optimality Score and General Movements)

Secondary Outcome Measures

Name	Time	Method
1. Mood, cognitive functioning and sleeping rhythm of the mother<br>2. LCP status in red blood cells of mother (16th and 36th week) and child (12 weeks after birth), umbilical cord, breast milk (2 and 12 weeks after birth)